SANGAMO THERAPEUTICS (SGMOQ) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 32 89 sessions, June 24, 2026 to October 28, 2026
- Largest daily move
- +31.4% close of July 2, 2026
- 1-month change
- -17.5% closing prices, September 28, 2026 to October 28, 2026
Company Description
SANGAMO THERAPEUTICS (OTC: SGMOQ) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $48.9M.
SGMOQ has declined 17.5% over the past month. The last closing price was $0.1180.
For FY2025, SANGAMO THERAPEUTICS reported revenue of $39.6M with net income of -$122.9M and diluted earnings per share of -$0.44.
This page collects what Stock Titan holds for SGMOQ, including price data, SEC filings, financial highlights, and short interest trends.
Stock Performance
SANGAMO THERAPEUTICS (SGMOQ) closed at $0.1180 on October 28, 2026. Over the past month, the price has lost 17.5%.
SGMOQ Metrics & Rankings
Price returns through October 28, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
SANGAMO THERAPEUTICS has filed 10 recent SEC filings, including 7 Form 8-K, 1 Form 25-NSE, 1 Form NT 10-Q, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on October 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SGMOQ SEC filings →
Financial Highlights
SANGAMO THERAPEUTICS generated $39.6M in revenue in FY2025, operating income reached -$121.2M, and net income was -$122.9M. Diluted earnings per share stood at -$0.44. The company generated -$97.2M in operating cash flow. The current ratio was 0.84, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in SANGAMO THERAPEUTICS (SGMOQ) currently stands at 9.3 million shares, down 13.1% from the previous reporting period, representing 2.3% of the float. Since June 2026, short interest has decreased by 41.4%.
Days to Cover History
Days to cover for SANGAMO THERAPEUTICS (SGMOQ) currently stands at 3.3 days. The ratio is the reported short interest divided by the average daily trading volume. Since June 2026, the figure has increased by 234%. Across the settlements charted above, it has ranged from 1.0 to 3.3 days.
SGMOQ Company Profile & Sector Positioning
SANGAMO THERAPEUTICS (SGMOQ) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.